n

%

No. of patients

19

Pt age (yr)

Median (Range)

65 (51 - 79)

No. ECOG performance status

0

13

68.4

1

4

21.1

2

2

10.5

Gleason score at diagnosis

≤6

2

10.5

7

2

10.5

≥8

14

73.7

unknown

1

5.3

Baseline PSA before DEC (ng/mL)

Median (Range)

67.0 (9.1 - 1102)

Median time from diagnosis to ADT (m)

Median (Range)

1.0 (0.0 - 1062)

Median time from diagnosis to docetaxel (m)

Median (Range)

27.0 (3.0 - 1313)

Median time from DP to DEC (m)

Median (Range)

13.0 (4.0 - 29.0)

Median time from CRPC to DEC (m)

Median (Range)

17.0 (5.0 - 57.0)

Median cycles of docetacel before DEC

6 (1 - 12)

Metastatic site

Bone

18

94.7

Lymph nodes

13

68.4

Visceral

5

26.3

Other

1

5.3

Prior therapy

Surgery

4

21.1

Radiation

2

10.5

Medical castration

15

78.9

Surgical castration

4

21.1

Bicalutamide

19

100.0

Flutamide

12

63.2

Chlormadinone acetate

3

15.8

EMP

16

84.2

Other

2

10.5